Search Results 1-10 of 16443 for dapagliflozine

  1. Dapagliflozin (oral route) - Side effects & dosage - Mayo Clinic

    Dapagliflozin is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) ...

  2. Dapagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Dapagliflozin and metformin combination is also used to lower the risk of worsening of kidney disease, end stage kidney disease, cardiovascular death, and ...

  3. Dapagliflozin, saxagliptin, and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Description. Dapagliflozin, saxagliptin, and metformin combination is used with proper diet and exercise to lower high blood sugar levels caused by type 2 ...

  4. Saxagliptin and dapagliflozin (oral route) - Mayo Clinic

    Dapagliflozin works in the kidneys to prevent absorption of glucose (blood sugar). ... Each tablet contains 5 milligrams (mg) saxagliptin and 5 mg dapagliflozin ...

  5. A Study of the Effect of Dapagliflozin on Symptoms and Biomarkers in Diabetes Patients with Heart Failure - Mayo Clinic

    The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure disease-specific biomarkers, symptoms, ...

  6. Dapagliflozin in Type 2 Diabetes or Pre-diabetes, and PRESERVED Ejection Fraction Heart Failure - Mayo Clinic

    The primary purpose of this study is to evaluate the impact of dapagliflozin, as compared with placebo, on heart failure, disease specific biomarkers, symptoms, ...

  7. A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease - Mayo Clinic

    A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease · More about research at ...

  8. Dapagliflozin (DAPA) Effects in HFpEF - Clinical Trials

    The purpose of this study is to determine whether treatment with Dapagliflozin (DAPA) for 6 months will improve pulmonary capillary wedge pressure (PCWP) during ...

  9. A Study to Evaluate Dapagliflozin to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure - Mayo Clinic

    The purpose of this international study is to evaluate the effect of dapagliflozin 10 mg versus placebo in HFpEF patients, given once daily in addition to ...

  10. A Study of Dapagliflozin in the Failing Fontan Circulation - Mayo Clinic

    About this study. The purpose of this study is to determine whether treatment with DAPA for 6 months will improve pulmonary capillary wedge pressure (PCWP) ...